NCT05364203View on ClinicalTrials.gov

Interest of Immersive Virtual Reality on Stress During Botulinum Toxin Injections in Spasticity (RVTOX)

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 10, 2022

Primary Completion Date

December 2, 2024

Study Completion Date

December 2, 2024

Conditions
Central Neurogical Impairment
Interventions
DEVICE

DEEPSEN virtual reality mask

DEEPSEN virtual reality mask with 360 ° vision. The audio-visual content will be chosen by the patient.

Trial Locations (1)

Unknown

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER